Nordic 5-fluorouracil/leucovorin bolus schedule combined with oxaliplatin (Nordic FLOX) as first-line treatment of metastatic colorectal cancerSØRBYE, Halfdan; DAHL, Olav.Acta oncologica (Stockholm). 2003, Vol 42, Num 8, pp 827-831, issn 0284-186X, 5 p.Article

Profiles and time course of acute radiation toxicity symptoms during conformal radiotherapy for cancer of the prostateHOVDENAK, Nils; KARLSDOTTIR, Asa; SØRBYE, Halfdan et al.Acta oncologica (Stockholm). 2003, Vol 42, Num 7, pp 741-748, issn 0284-186X, 8 p.Article

Oxaliplatin-induced haematological emergency with an immediate severe thrombocytopenia and haemolysisSØRBYE, Halfdan; BRUSERUD, Øystein; DAHL, Olav et al.Acta oncologica (Stockholm). 2001, Vol 40, Num 7, pp 882-883, issn 0284-186XArticle

The influence of combretastatin A-4 and vinblastine on interstitial fluid pressure in BT₄An rat gliomasEIKESDAL, Hans Petter; LANDUYT, Willy; DAHL, Olav et al.Cancer letters. 2002, Vol 178, Num 2, pp 209-217, issn 0304-3835Article

Vinblastine and hyperthermia target the neovasculature in BT₄AN rat gliomas : Therapeutic implications of the vascular phenotypeEIKESDAL, Hans Petter; BJERKVIG, Rolf; DAHL, Olav et al.International journal of radiation oncology, biology, physics. 2001, Vol 51, Num 2, pp 535-544, issn 0360-3016Article

Norwegian oncologists' expectations of intensity-modulated radiotherapyMUREN, Ludvig P; MELLA, Olav; HAFSLUND, Rune et al.Acta oncologica (Stockholm). 2002, Vol 41, Num 6, pp 562-565, issn 0284-186X, 4 p.Article

Global gene expression analyses reveal changes in biological processes after hyperthermia in a rat glioma modelBORKAMO, Erling Dahl; DAHL, Olav; BRULAND, Ove et al.International journal of hyperthermia. 2008, Vol 24, Num 5, pp 425-441, issn 0265-6736, 17 p.Article

Current status of antivascular therapy and targeted treatment in the clinicDAHL, Olav; BORKAMO, Erling Dahl; FLUGE, Øystein et al.International journal of hyperthermia. 2008, Vol 24, Num 1, pp 97-110, issn 0265-6736, 14 p.Conference Paper

Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parametersPAUL MUREN, Ludvig; JEBSEN, Nina; GUSTAFSSON, Anders et al.International journal of radiation oncology, biology, physics. 2001, Vol 50, Num 3, pp 627-637, issn 0360-3016Article

Kinetics study on markers of the immune system by gene expression profiling of an in vivo heated tumorBORKAMO, Erling Dahl; DAHL, Olav; BRULAND, Ove et al.International journal of hyperthermia. 2009, Vol 25, Num 1, pp 41-46, issn 0265-6736, 6 p.Article

PROGNOSTIC IMPACT OF ERYTHROPOIETIN EXPRESSION AND ERYTHROPOIETIN RECEPTOR EXPRESSION ON LOCOREGIONAL CONTROL AND SURVIVAL OF PATIENTS IRRADIATED FOR STAGE II/III NON-SMALL-CELL LUNG CANCERRADES, Dirk; SETTER, Cornelia; DAHL, Olav et al.International journal of radiation oncology, biology, physics. 2011, Vol 80, Num 2, pp 499-505, issn 0360-3016, 7 p.Article

Cardiovascular Risk Factors and Morbidity in Long-Term Survivors of Testicular Cancer: A 20-Year Follow-Up StudyHAUGNES, Hege S; WETHAL, Torgeir; AASS, Nina et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4649-4657, issn 0732-183X, 9 p.Article

Is the sexual function compromised in long-term testicular cancer survivors?DAHL, Alu A; BREMNES, Roy; DAHL, Olav et al.European urology. 2007, Vol 52, Num 5, pp 1438-1447, issn 0302-2838, 10 p.Article

Brachytherapy for prostate cancer: A systematic review of clinical and cost effectivenessNORDERHAUG, Inger; DAHL, Olav; HØISAETER, Per A et al.European urology. 2003, Vol 44, Num 1, pp 40-46, issn 0302-2838, 7 p.Article

Phase III Trial of Cetuximab With Continuous or Intermittent Fluorouracil, Leucovorin, and Oxaliplatin (Nordic FLOX) Versus FLOX Alone in First-Line Treatment of Metastatic Colorectal Cancer: The NORDIC-VII StudyMAGNE TVEIT, Kjell; GUREN, Tormod; FOKSTUEN, Tone et al.Journal of clinical oncology. 2012, Vol 30, Num 15, pp 1755-1762, issn 0732-183X, 8 p.Article

Paternity and Testicular Function Among Testicular Cancer Survivors Treated With Two to Four Cycles of Cisplatin-Based Chemotherapy. CommentaryBRYDØY, Marianne; FOSSA, Sophie D; KLEPP, Olbjøm et al.European urology. 2010, Vol 58, Num 1, pp 134-141, issn 0302-2838, 8 p.Article

Observational Study of Prevalence of Long-term Raynaud-Like Phenomena and Neurological Side Effects in Testicular Cancer SurvivorsBRYDØY, Marianne; OLDENBURG, Jan; KLEPP, Olbjørn et al.Journal of the National Cancer Institute. 2009, Vol 101, Num 24, pp 1682-1695, issn 0027-8874, 14 p.Article

Dosimetric verification of a dedicated 3D treatment planning system for episcleral plaque therapyKNUTSEN, Stig; HAFSLUND, Rune; MONGE, Odd R et al.International journal of radiation oncology, biology, physics. 2001, Vol 51, Num 4, pp 1159-1166, issn 0360-3016Article

Management of Seminomatous Testicular Cancer: A Binational Prospective Population-Based Study From the Swedish Norwegian Testicular Cancer Study GroupTANDSTAD, Torgrim; SMAALAND, Rune; DAHL, Olav et al.Journal of clinical oncology. 2011, Vol 29, Num 6, pp 719-725, issn 0732-183X, 7 p.Article

Clinical characteristics and outcomes in patients with advanced Rectal Cancer : A national prospective cohort studyKJARTAN SIGURDSSON, Helgi; KÖRNER, Hartwig; DAHL, Olav et al.Diseases of the colon & rectum. 2007, Vol 50, Num 3, pp 285-288, issn 0012-3706, 4 p.Article

First results of triple-modality treatment combining radiotherapy, chemotherapy, and hyperthermia for the treatment of patients with stage IIB, III, and IVA cervical carcinomaWESTERMANN, Anneke M; JONES, Ellen L; VAN DER WILT, Clasina L et al.Cancer. 2005, Vol 104, Num 4, pp 763-770, issn 0008-543X, 8 p.Article

Population-Based Study of Treatment Guided by Tumor Marker Decline in Patients With Metastatic Nonseminomatous Germ Cell Tumor: A Report From the Swedish-Norwegian Testicular Cancer GroupOLOFSSON, Sven-Erik; TANDSTAD, Torgrim; SOLBERG, Arne et al.Journal of clinical oncology. 2011, Vol 29, Num 15, pp 2032-2039, issn 0732-183X, 8 p.Article

A study of coping in long-term testicular cancer survivorsRUTSKIJ, Robert; GAARDEN, Torfinn; BREMNES, Roy et al.Psychology, health & medicine. 2010, Vol 15, Num 2, pp 146-158, issn 1354-8506, 13 p.Article

Side effects and cancer-related stress determine quality of life in long-term survivors of testicular cancerMYKLETUN, Arnstein; DAHL, Alv A; HAALAND, Carl Fredrik et al.Journal of clinical oncology. 2005, Vol 23, Num 13, pp 3061-3068, issn 0732-183X, 8 p.Article

FIBROBLAST GROWTH FACTOR 2—A PREDICTOR OF OUTCOME FOR PATIENTS IRRADIATED FOR STAGE II-III NON―SMALL-CELL LUNG CANCERRADES, Dirk; SETTER, Cornelia; DAHL, Olav et al.International journal of radiation oncology, biology, physics. 2012, Vol 82, Num 1, pp 442-447, issn 0360-3016, 6 p.Article